Ae Saekhou Youngpairoj

Title: **Innovator Spotlight: Ae Saekhou Youngpairoj**

Introduction

Ae Saekhou Youngpairoj is a prominent inventor based in Snellville, Georgia, known for her significant contributions to biomedical research. With a focus on drug detection and compliance, she has developed innovative solutions that enhance the understanding of antiretroviral treatments.

Latest Patents

Ae Saekhou Youngpairoj holds a patent for a monoclonal antibody designed for the detection of emtricitabine (FTC), an antiretroviral drug. Her invention involves monoclonal antibodies that specifically bind to FTC, enabling the detection of this drug in various samples. The methods outlined in her patent can be used to assess whether a subject is adhering to therapeutic or prophylactic protocols, as well as to determine the appropriate dosage of FTC for administration.

Career Highlights

Ae’s career is marked by her dedication to advancing healthcare through innovation. Her work, particularly in developing methodologies for detecting antiretroviral drugs, showcases her commitment to improving patient care and compliance. Working under the auspices of the Government of the United States of America as represented by the Secretary of the Department of Health and Human Services, she plays a crucial role in public health initiatives.

Collaborations

In her professional journey, Ae has collaborated with notable individuals, including Timothy Clyde Granade and William M. Switzer. These collaborations contribute to her research, enhancing the impact of her innovative solutions in the healthcare sector.

Conclusion

Ae Saekhou Youngpairoj exemplifies the spirit of innovation in the field of biomedical research. Her patent for the detection of emtricitabine not only highlights her expertise but also underscores the importance of compliance in therapeutic treatments. Through her work and collaborations, she continues to make a significant impact on public health and innovation.